Rice bran polysaccharide as well as extraction method and application thereof
By extracting and applying rice bran polysaccharides, the problem of lacking safe and inexpensive natural active ingredients to alleviate food allergies in existing technologies has been solved, achieving significant relief of food allergy symptoms and improvement of gut health.
Patent Information
- Application Number
- CN202411299470.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-18
- Publication Date
- 2024-11-26
AI Technical Summary
There is a lack of safe, widely available and inexpensive natural active ingredients in the current technology to effectively relieve food allergy symptoms, and existing drugs have problems with side effects and easy recurrence of allergies.
A rice bran polysaccharide with a molecular weight of 3.72 kDa was extracted. Its monosaccharide composition includes arabinose, galacturonic acid, glucose, galactose, xylose, and glucuronic acid. High-purity rice bran polysaccharide was obtained through specific enzyme treatment and dialysis methods, and it was applied to products for the prevention and treatment of food allergies.
Rice bran polysaccharides significantly alleviate food allergy symptoms, reduce the levels of allergen-specific IgE, histamine, and IL-4, regulate Th1/Th2 differentiation, improve intestinal damage, enhance the integrity of colonic epithelial cells, regulate the NF-κB signaling pathway, and provide a safe and effective anti-allergy solution.
Smart Images

Figure CN119019577A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of natural active ingredient extraction, and in particular relates to rice bran polysaccharide and an extraction method and application thereof. Background Art
[0002] Food allergy (FA) is a global health problem, and its incidence is increasing year by year. It has become a major issue in the field of food safety and public health. Due to the multi-cause, complex and comprehensive characteristics of FA, there is currently no ideal treatment. Although commonly used drugs such as antihistamines, mast cell stabilizers and immunosuppressants can quickly relieve allergic symptoms, they have side effects and allergies are prone to recurrence. Biological agents (anti-IL-4Ra, anti-IgE) and oral immunotherapy are promising treatment methods, but the high price of biological agents and the safety of oral immunotherapy are considered to be important limiting factors for their routine clinical application. In order to find safer and more effective solutions, more and more researchers are committed to using natural active ingredients to develop anti-allergic foods or drugs.
[0003] Therefore, it is particularly important to provide a safe, widely available and inexpensive natural active ingredient that can effectively relieve food allergy symptoms. Summary of the invention
[0004] In view of this, the object of the present invention is to provide a rice bran polysaccharide which has a good improving effect on food allergies.
[0005] Another object of the present invention is to provide a method for extracting the rice bran polysaccharide.
[0006] Another object of the present invention is to provide an application of the rice bran polysaccharide in the preparation of a product for preventing and / or treating food allergies.
[0007] Another object of the present invention is to provide a drug for preventing and / or treating food allergy.
[0008] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0009] The invention provides a rice bran polysaccharide. The molecular weight of the rice bran polysaccharide is 3.72 kDa. The monosaccharide composition of the rice bran polysaccharide comprises arabinose, galacturonic acid, glucose, galactose, xylose and glucuronic acid. The molar ratio of the arabinose, galacturonic acid, glucose, galactose, xylose and glucuronic acid is 6.95:2.13:82.93:5.15:2.07:0.18.
[0010] Preferably, the structure of the rice bran polysaccharide comprises:
[0011] →[4)-α-D-Glcp-(1)n →6)-β-D-Galp-(1→4)-α-D-Glcp-(1→4)-α-D-Glcp-(1→circular is the main chain, and the side chains include α-D-Glcp-(1→ connected to the O-6 position of the sugar residue →4,6)-α-D-Glcp-(1→ and α-L-Araf-(1→ connected to the O-3 position of the sugar residue →3,6)-β-D-Galp-(1→).
[0012] The present invention also provides a method for extracting the rice bran polysaccharide, comprising the following steps:
[0013] The rice bran is mixed with petroleum ether for defatting to obtain defatted rice bran; the defatted rice bran is extracted in water and the supernatant is collected; α-amylase, papain and Sevag method are used to remove starch and protein in the supernatant and the supernatant from which the starch and protein are removed is collected; the supernatant from which the starch and protein are removed is concentrated and precipitated with alcohol to obtain a precipitate; the precipitate is dialyzed with deionized water to obtain a dialysate; the dialysate is concentrated and precipitated with alcohol and the precipitate is dried to obtain rice bran polysaccharide.
[0014] Preferably, the extraction conditions are: extraction at 85-95° C. for 1-3 h.
[0015] Preferably, the α-amylase treatment conditions are: treatment at 75-85° C. for 0.2-1 h.
[0016] Preferably, the papain treatment conditions are: treatment at 55-65° C. for 1-3 hours.
[0017] Preferably, the molecular weight cut-off of the dialysis is 1500-2500 Da.
[0018] The present invention also provides an application of the rice bran polysaccharide in preparing a product for preventing and / or treating food allergies.
[0019] Preferably, the allergen of food allergy includes ovalbumin.
[0020] The present invention also provides a medicine for preventing and / or treating food allergy, which comprises a pharmaceutically acceptable carrier and the rice bran polysaccharide.
[0021] Preferably, the dosage form of the drug includes oral preparation, spray or injection.
[0022] Beneficial effects of the present invention:
[0023] The rice bran polysaccharide extracted by the extraction method of the invention has an extraction rate of 4.32%, a total sugar content in the polysaccharide of 75.28%, a small amount of impurities, and a high purity of the rice bran polysaccharide. The rice bran polysaccharide extracted by the invention has a molecular weight of 3.72 kDa and is composed of arabinose, galacturonic acid, glucose, galactose, xylose and glucuronic acid.
[0024] The invention establishes an OVA-sensitized mouse allergy model and conducts in vivo mouse experimental verification, indicating that rice bran polysaccharides can significantly alleviate food allergy symptoms, including weight loss, rectal temperature reduction and clinical allergy symptom score increase caused by food allergy. Rice bran polysaccharides can also reduce the content of allergen-specific IgE, histamine and cytokine IL-4 in serum, inhibit the gene expression of intestinal epithelial cytokines (IL-33 and TSLP), IL-6, Th2 cytokine IL-4 and transcription factor GATA-3 caused by food allergy, and enhance the gene expression of Tregs (IL-10). At the same time, rice bran polysaccharides can regulate Th1 / Th2 differentiation to achieve dynamic balance and downregulate Th2 polarization caused by food allergy. Rice bran polysaccharides can also effectively improve intestinal damage, significantly upregulate the expression of tight junction proteins in colon epithelial cells, and promote the integrity of epithelial cells. Rice bran polysaccharides can improve food allergy reactions by regulating the NF-κB signaling pathway. Rice bran polysaccharides have a good improvement effect on food allergies, providing better theoretical support for the development of anti-allergic or allergy-preventing foods and drugs. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 The results of the molecular weight test of rice bran polysaccharides by high performance liquid chromatography method in Experimental Example 2 are as follows;
[0026] Figure 2 The results of the test of monosaccharide composition of rice bran polysaccharides by high performance anion exchange chromatography amperometric detection in Experimental Example 2;
[0027] Figure 3 This is the test result of rice bran polysaccharide methylation in Experimental Example 2;
[0028] Figure 4 The one-dimensional and two-dimensional NMR detection results of rice bran polysaccharide in Experimental Example 2, where A is the H spectrum, B is the C spectrum, C is the COSY spectrum, D is the NOESY spectrum, E is the HSQC spectrum, and F is the HMBC spectrum;
[0029] Figure 5 The flowchart of the construction of the Balb / c mouse sensitization model and the in vivo experimental scheme in Experimental Example 3;
[0030] Figure 6 The weekly weight changes of mice in each group in Experimental Example 3; A is a line graph of weekly weight changes of mice in each group, and B is a heat map of weekly weight changes of mice in each group;
[0031] Figure 7 The clinical symptom scores of allergic reactions in each group of mice after challenge in Experiment 3;
[0032] Figure 8 are the rectal temperatures and rectal temperature differences of mice in each group in Experimental Example 3; wherein A is the rectal temperature of mice 30 minutes before and after the challenge, and B is the difference between the rectal temperatures of mice 30 minutes after the challenge and 30 minutes before the challenge;
[0033] Fig. 9 The changes in the levels of OVA-specific IgE, IgG1 and IgG2a in the serum of each group of mice in Experimental Example 3; A is the change in IgE level, B is the change in IgG1 level, and C is the change in IgG2a level;
[0034] Fig.10 The concentrations of histamine, IL-4 and IFN-γ in the serum of each group of mice in Experimental Example 3 are shown in Figure 3; A is the concentration change of histamine, B is the concentration change of IL-4, and C is the concentration change of IFN-γ;
[0035] Fig.11 is the relative expression of TSLP gene in the large intestine and small intestine of each group of mice in Experimental Example 3; wherein A is the relative expression of TSLP gene in the large intestine, and B is the relative expression of TSLP gene in the small intestine;
[0036] Fig.12 is the relative expression of IL-33 gene in the large intestine and small intestine of each group of mice in Experimental Example 3; wherein A is the relative expression of IL-33 gene in the large intestine, and B is the relative expression of IL-33 gene in the small intestine;
[0037] Fig.13 is the relative expression level of IL-6 and IL-10 genes in the spleen, large intestine and small intestine of each group of mice in Experimental Example 3; wherein A is the relative expression level of IL-6 gene, and B is the relative expression level of IL-10 gene;
[0038] Fig.14 is the expression level of T cell allergy-related genes in the spleen, large intestine and small intestine of each group of mice in Experimental Example 3; wherein A is the expression level of T cell allergy-related genes in the spleen, B is the expression level of T cell allergy-related genes in the large intestine, and C is the expression level of T cell allergy-related genes in the small intestine;
[0039] Fig.15 The proportion of Th2 cells in the CD4+ cells in the spleen of each group of mice in Experimental Example 3; wherein A is a flow cytometric graph of the proportion of Th2 cells (TS2) in the spleen of each group of mice, B is a bar graph of the proportion of Th2 cells in each group, C is a flow cytometric graph of the proportion of Th1 cells (CD183) in the spleen of each group of mice, and D is a bar graph of the proportion of Th1 cells in each group;
[0040] Fig.16 The H&E staining results of the ileum and duodenum of each group of mice in Experimental Example 3; A is the H&E staining result of the ileum, and B is the H&E staining result of the duodenum;
[0041] Fig.17 is the expression level of tight junction protein-related genes in the colon of each group of mice in Experimental Example 3; wherein A is the expression level of ZO-1 gene, B is the expression level of Occludin gene, and C is the expression level of Claudin-1 gene;
[0042] Fig.18 The expression of NF-κB protein in the spleen of each group of mice in Experimental Example 3; A is a strip diagram, and B is the ratio of p-NF-κB to NF-κB. DETAILED DESCRIPTION
[0043] The invention provides a rice bran polysaccharide. The molecular weight of the rice bran polysaccharide is 3.72 kDa. The monosaccharide composition of the rice bran polysaccharide comprises arabinose, galacturonic acid, glucose, galactose, xylose and glucuronic acid. The molar ratio of the arabinose, galacturonic acid, glucose, galactose, xylose and glucuronic acid is 6.95:2.13:82.93:5.15:2.07:0.18.
[0044] In the present invention, the structure of the rice bran polysaccharide comprises:
[0045] →[4)-α-D-Glcp-(1) n →6)-β-D-Galp-(1→4)-α-D-Glcp-(1→4)-α-D-Glcp-(1→circular is the main chain, and the side chains include α-D-Glcp-(1→ connected to the O-6 position of the sugar residue →4,6)-α-D-Glcp-(1→ and α-L-Araf-(1→ connected to the O-3 position of the sugar residue →3,6)-β-D-Galp-(1→).
[0046] In the present invention, the method for extracting rice bran polysaccharides preferably comprises the following steps:
[0047] The rice bran is mixed with petroleum ether for defatting to obtain defatted rice bran; the defatted rice bran is extracted in water and the supernatant is collected; α-amylase, papain and Sevag method are used to remove starch and protein in the supernatant and the supernatant from which the starch and protein are removed is collected; the supernatant from which the starch and protein are removed is concentrated and precipitated with alcohol to obtain a precipitate; the precipitate is dialyzed with deionized water to obtain a dialysate; the dialysate is concentrated and precipitated with alcohol and the precipitate is dried to obtain rice bran polysaccharide.
[0048] In the present invention, the type and source of the rice bran are not particularly limited and can be conventionally selected according to actual needs. As an implementation method, the rice bran can be sieved before defatting; the mesh number of the sieve is not particularly limited and can be conventionally selected according to actual needs, preferably 20 to 60 meshes, more preferably 30 to 50 meshes, and more preferably 60 meshes.
[0049] In the present invention, rice bran is mixed with petroleum ether for defatting to obtain defatted rice bran. The boiling range of petroleum ether is not particularly limited and can be conventionally selected according to actual needs; preferably, it is a boiling range of 30-60°C. In the present invention, as an implementable embodiment, the mass volume ratio of rice bran to petroleum ether is preferably 1g:3-8mL, further preferably 1g:4-6mL, and more preferably 1g:5mL; the degreasing method is preferably stirring, and the stirring rate is not particularly limited; the degreasing time is preferably 2-6h, further preferably 3-5h, and more preferably 4h. The number of degreasing can be conventionally selected according to the actual degreasing situation, preferably 2-4 times, and more preferably 3 times. In the present invention, as an implementable embodiment, after rice bran is mixed with petroleum ether for defatting, petroleum ether is removed and dried to obtain defatted rice bran; the petroleum ether removal method can be conventionally selected according to actual needs, and as an optional embodiment, petroleum ether is removed by filtering; the drying method is not particularly limited, and as an optional embodiment, it is placed in a ventilated place for air drying.
[0050] In the present invention, defatted rice bran is leached in water and the supernatant is collected. The present invention has no particular limitation on the type of water, including but not limited to distilled water, double distilled water, triple distilled water, ultrapure water, deionized water, etc. The mass ratio of defatted rice bran to water is preferably 1:10-20, more preferably 1:14-16, and more preferably 1:15. The leaching temperature is preferably 85-95°C, more preferably 87.5-92.5°C, and more preferably 90°C; the leaching time is preferably 1-3h, more preferably 1.5-2.5h, and more preferably 2h; the number of leaching is preferably 1-3 times, and more preferably 2 times. In the present invention, as an implementation method, filtration is performed after extraction, and the filtrate is collected and combined; the filtering method is not particularly limited; the filtrate is combined and then centrifuged to collect the supernatant, and the centrifugal conditions can be conventionally selected according to actual needs. As an optional implementation method, the centrifugal speed is preferably 8000-12000r / min, more preferably 9000-11000r / min, and more preferably 10000r / min; the centrifugal time is preferably 3-8min, more preferably 4-6min, and more preferably 5min; the number of centrifugation is preferably 1-3 times, and more preferably 2 times.
[0051] In the present invention, α-amylase, papain and Sevag method are used to remove starch and protein in the supernatant, and the supernatant from which starch and protein are removed is collected. As an implementable method, α-amylase is added to the supernatant to remove starch; the α-amylase is preferably a thermostable α-amylase; the enzyme activity of the α-amylase is preferably 0.5-2U / g, more preferably 0.7-1.5U / g, and more preferably 1U / g; the amount of the α-amylase can be conventionally selected according to actual needs, preferably after the treatment is completed, the I2-KI solution is used to detect negative; the treatment temperature of the α-amylase is preferably 75-85°C, more preferably 77.5-82.5°C, and more preferably 80°C; the treatment time of the α-amylase is preferably 0.2-1h, more preferably 0.4-0.8h, and more preferably 0.5h. As an implementable method, after using α-amylase to remove starch, papain is added to precipitate the protein. The enzymatic activity of the papain is preferably 600-1000U / mg, more preferably 700-900U / mg, and more preferably 800U / mg; in terms of mass percentage, the amount of the papain is preferably 0.5%-3% of the mass of the rice bran, more preferably 1-2%, and more preferably 1.5%; the treatment temperature of the papain is preferably 55-65°C, more preferably 57.5-62.5°C, and more preferably 60°C; the treatment time of the papain is preferably 1-3h, more preferably 1.5-2.5h, and more preferably 2h. As an embodiment, after the protein is precipitated using papain, the enzyme is inactivated, the precipitate is removed, and the supernatant is obtained. The enzyme inactivation method can be conventionally selected according to actual needs. As an optional embodiment, the enzyme is inactivated by heating and boiling, and the heating and boiling time is preferably 10-20min, and more preferably 15min. The method of removing the precipitate may optionally include removing the precipitate by centrifugation; the centrifugal conditions may be conventionally selected according to actual needs. As an optional embodiment, the centrifugal speed is preferably 6000-10000 r / min, more preferably 7000-9000 r / min, and more preferably 8000 r / min; the centrifugal time is preferably 3-8 min, more preferably 4-6 min, and more preferably 5 min. As an embodiment, after the enzyme is inactivated and the precipitate is removed to obtain the supernatant, the protein is removed by the Sevag method. The step of removing protein by the Sevag method preferably includes: mixing the supernatant obtained by inactivating the enzyme and removing the precipitate with the Sevag reagent, stirring, standing for stratification, removing the middle layer and the lower layer, and the supernatant obtained is the supernatant from which starch and protein are removed.The Sevag reagent can be conventionally selected according to actual needs, preferably a reagent with a volume ratio of chloroform and n-butanol of 4:1; the volume ratio of the supernatant obtained by inactivating the enzyme and removing the precipitate to the Sevag reagent is preferably 1:1.5-3, more preferably 1:2; the stirring can be carried out in a conventional manner, including manual stirring or machine stirring; as an optional embodiment, a magnetic stirrer can be selected for stirring, and the stirring speed is preferably 500-900r / min, more preferably 600-800r / min, more preferably 700r / min; the stirring time is preferably 10-20min, more preferably 12-17min, more preferably 15min; the standing time is not particularly limited, preferably standing until the liquid is divided into three layers. The number of operations for removing protein by the Sevag method can be conventionally selected according to actual needs, preferably until no protein layer appears.
[0052] In the present invention, the supernatant from which starch and protein are removed is concentrated and precipitated with alcohol to obtain a precipitate. The method of concentration is not particularly limited. As an implementable method, a rotary evaporator can be used for concentration; the volume of the concentration is not particularly limited and can be conventionally selected according to actual needs. In the present invention, the step of alcohol precipitation preferably includes: adding an alcohol solution to the concentrated concentrate, standing, centrifuging, and obtaining a precipitate. The alcohol solution is preferably an ethanol solution; the volume concentration of the alcohol solution is preferably 90% to 98%, more preferably 95%; the volume of the alcohol solution is preferably 2 to 4 times the volume of the concentrate, more preferably 3 times; the standing temperature is preferably 2 to 6°C, more preferably 4°C; the standing time is preferably 8 to 12h; the present invention does not specifically limit the speed and time of the centrifugation, which can be conventionally selected according to actual needs.
[0053] In the present invention, the precipitate is dialyzed with deionized water to obtain a dialysate. The molecular weight cutoff of the dialysis is preferably 1500-2500Da, more preferably 2000Da. As an implementable method, a dialysis bag is used for dialysis treatment; the dialysis bag is preferably pretreated before use to remove impurities on the dialysis bag. The pretreatment step preferably includes: boiling the dialysis bag in a boiling water bath, cooling to room temperature, immersing it in an alcohol solution, and storing it for standby use. The dialysis bag is cut into the required length according to actual needs, preferably 20-30cm, more preferably 25cm; the boiling time is preferably 10-20min, more preferably 15min; the alcohol solution is preferably ethanol solution; the volume concentration of the alcohol solution is preferably 15%-25%, more preferably 20%; the storage temperature is preferably 2-6°C, more preferably 4°C. As an implementable method, the dialysis treatment step preferably includes: dissolving the precipitate in distilled water to obtain a polysaccharide solution, loading the polysaccharide solution into a dialysis bag, and dialyzing with deionized water. The mass ratio of the precipitate to the distilled water is preferably 1:6-15, more preferably 1:8-12, and more preferably 1:10; the amount of the polysaccharide solution loaded into the dialysis bag can be conventionally selected according to actual needs, preferably 20-50 mL, more preferably 30 mL; the number of the dialysis bags can be conventionally selected according to actual needs; the amount of deionized water can be conventionally selected according to actual needs, preferably 4000-6000 mL, more preferably 4500-5500 mL, more preferably 5000 mL; the dialysis time is preferably 62-70 h, further preferably 62-70 h. The step is preferably 64 to 68 hours, more preferably 66 hours; as an optional embodiment, deionized water is replaced according to actual needs during the dialysis process; in some embodiments, the water is replaced every 1.5 to 3 hours for the first 8 to 12 hours, and then every 7 to 9 hours; in some embodiments, the water is replaced every 2 hours for the first 8 to 12 hours, and then every 7 to 9 hours; in other embodiments, the water is replaced every 1.5 to 3 hours for the first 8 to 12 hours, and then every 8 hours; as an optional embodiment, the water is replaced every 2 hours for the first 10 hours, and then every 8 hours.
[0054] In the present invention, the dialysate is concentrated, precipitated with alcohol, and the precipitation is dried to obtain rice bran polysaccharide. The concentration method can be conventionally selected according to actual needs; the volume of the dialysate after concentration is not particularly limited and can be conventionally selected according to actual needs; the step of alcohol precipitation preferably includes: adding an alcohol solution to the concentrated dialysate, standing, centrifuging, and obtaining a precipitate. The alcohol solution is preferably an ethanol solution; the volume concentration of the alcohol solution is preferably 90% to 98%, more preferably 95%; the volume of the alcohol solution is preferably 2 to 4 times the volume of the concentrated dialysate, more preferably 3 times; the standing temperature is preferably 2 to 6°C, more preferably 4°C; the standing time is preferably 8 to 12h; the present invention does not specifically limit the speed and time of the centrifugation, which can be conventionally selected according to actual needs. The drying method can select a conventional drying method. As an implementable method, vacuum freeze drying is used for drying, and the vacuum freeze drying conditions can be conventionally selected according to actual needs.
[0055] According to the extraction method of the present invention, rice bran polysaccharide is extracted, the extraction rate of rice bran polysaccharide reaches 4.32%, the total sugar content in the polysaccharide reaches 75.28%, the impurity content is small, and the rice bran polysaccharide has high purity.
[0056] The present invention also provides an application of the rice bran polysaccharide in preparing a product for preventing and / or treating food allergies.
[0057] In the present invention, rice bran polysaccharides can significantly alleviate food allergy symptoms, including weight loss, decreased rectal temperature, and increased clinical allergy symptom scores. Rice bran polysaccharides can also reduce the content of allergen-specific IgE, histamine and cytokine IL-4 in serum, inhibit the gene expression of intestinal epithelial cytokines (IL-33 and TSLP), IL-6, Th2 cytokine IL-4 and transcription factor GATA-3 caused by food allergies, and enhance the gene expression of Tregs (IL-10). At the same time, rice bran polysaccharides can regulate Th1 / Th2 differentiation to achieve dynamic balance and downregulate Th2 polarization caused by food allergies. Rice bran polysaccharides can also effectively improve intestinal damage, significantly upregulate the expression of tight junction proteins in colon epithelial cells, and promote the integrity of epithelial cells. Rice bran polysaccharides can improve food allergic reactions by regulating the NF-κB signaling pathway. In the present invention, the allergen of food allergy preferably includes ovalbumin.
[0058] The present invention also provides a medicine for preventing and / or treating food allergy, which comprises a pharmaceutically acceptable carrier and the rice bran polysaccharide.
[0059] In the present invention, there is no particular limitation on the dosage form of the drug, and it can be conventionally selected according to actual needs, including but not limited to oral agents, sprays or injections. Examples of oral agents include powders, tablets, granules, capsules, solutions, emulsions, suspensions, etc. Examples of sprays include sprays, aerosols, powder sprays, etc. The carrier can be conventionally selected according to the drug dosage form and actual needs.
[0060] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0061] In the following embodiments, unless otherwise specified, all of them are conventional methods.
[0062] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0063] Example 1
[0064] A method for extracting rice bran polysaccharides:
[0065] (1) Extraction of polysaccharides: 1.0 kg of rice bran screened with a 40-mesh sieve was mixed with 5 L of petroleum ether with a boiling range of 30-60°C, and stirred in a fume hood for 4 h for defatting. After repeating this operation three times, the petroleum ether was filtered out, and the residue was air-dried in a fume hood. Defatted rice bran was extracted with distilled water at a mass ratio of 1:15 at 90°C for 2 h, extracted twice, filtered, and the filtrate was centrifuged at a rate of 10,000 r / min for 5 min, centrifuged twice, the precipitate was removed, and the supernatant was retained.
[0066] (2) Removal of starch and protein: The supernatant obtained by the above centrifugation was further treated with a thermostable α-amylase (1.0 U / g) at 80°C for 0.5 h to degrade the starch, and the I2-KI solution test was negative. Then 800 U / mg of papain (1.5% of the weight of rice bran) was added and reacted at 60°C for 2 h to degrade the protein. After boiling for 15 min to inactivate the enzyme activity, the supernatant was removed by centrifugation at 8000 r / min for 5 min to obtain the supernatant. The supernatant was mixed with Sevag reagent (chloroform: n-butanol volume ratio of 4:1) at a volume ratio of 1:2, stirred with a magnetic stirrer at 700 r / min for 15 min, poured into a separating funnel, and allowed to stand until the liquid was separated into three layers, the middle layer and the lower layer were removed, and the above operation was repeated 6 times until no significant protein layer appeared. The supernatant was collected and concentrated by a rotary evaporator, and then 3 times the volume of a 95% ethanol solution was added to the concentrate. The suspension was placed in a 4° C. refrigerator overnight and centrifuged to obtain a precipitate.
[0067] (3) Dialysis treatment
[0068] 1) Dialysis bag pretreatment: The molecular weight cutoff of the dialysis bag is 2000Da. The dialysis bag cut into appropriate length (about 25cm) is placed in a boiling water bath for 15 minutes. After cooling, it is immersed in a 20% ethanol solution by volume and stored in a refrigerator at 4°C for subsequent use.
[0069] 2) Polysaccharide dialysis: The precipitate obtained in step (2) is redissolved in distilled water to obtain a polysaccharide solution, the mass ratio of the precipitate to the distilled water is 1:10, 30 mL of the polysaccharide solution is placed in a dialysis bag, and dialyzed with 5000 mL of deionized water for 66 hours, with the water changed every 2 hours for the first 10 hours and every 8 hours for the next 56 hours. After the dialysis of the polysaccharide solution is completed, the dialysate is concentrated, 3 times the volume of 95% ethanol is added thereto and mixed evenly, the mixed solution is placed at 4°C for overnight, centrifuged to obtain a precipitate, and the precipitate is vacuum freeze-dried to obtain rice bran polysaccharide.
[0070] Example 2
[0071] A method for extracting rice bran polysaccharides:
[0072] (1) Extraction of polysaccharides: 1.0 kg of rice bran screened with a 20-mesh sieve was mixed with 8 L of petroleum ether with a boiling range of 30-60°C, and stirred in a fume hood for 6 h for defatting. After repeating this operation four times, the petroleum ether was filtered out, and the residue was air-dried in a fume hood. Defatted rice bran was extracted with distilled water at a mass ratio of 1:20 at 95°C for 1 h, extracted 3 times, filtered, and the filtrate was centrifuged at a rate of 12000 r / min for 3 min, centrifuged three times, the precipitate was removed, and the supernatant was retained.
[0073] (2) Removal of starch and protein: The supernatant obtained by the above centrifugation was further treated with a thermostable α-amylase (2.0 U / g) at 85°C for 0.2 h to degrade the starch, and the I2-KI solution test was negative. Then 600 U / mg of papain (3% of the weight of rice bran) was added and reacted at 65°C for 1 h to degrade the protein. After boiling for 20 min to inactivate the enzyme activity, the supernatant was removed by centrifugation at 10,000 r / min for 3 min to obtain the supernatant. The supernatant was mixed with Sevag reagent (chloroform: n-butanol volume ratio of 4:1) at a volume ratio of 1:3, stirred with a magnetic stirrer at 900 r / min for 10 min, poured into a separating funnel, and allowed to stand until the liquid was separated into three layers, the middle layer and the lower layer were removed, and the above operation was repeated 5 times until no significant protein layer appeared. The supernatant was collected and concentrated by a rotary evaporator, and then 4 times the volume of a 90% ethanol solution was added to the concentrate. The suspension was placed in a refrigerator at 2° C. overnight and centrifuged to obtain a precipitate.
[0074] (3) Dialysis treatment
[0075] 1) Dialysis bag pretreatment: The molecular weight cutoff of the dialysis bag is 2500Da. The dialysis bag cut into appropriate length (about 30cm) is placed in a boiling water bath for 20 minutes. After cooling, it is immersed in a 25% ethanol solution by volume and stored in a refrigerator at 2°C for subsequent use.
[0076] 2) Polysaccharide dialysis: The precipitate obtained in step (2) is redissolved in distilled water to obtain a polysaccharide solution, the mass ratio of the precipitate to the distilled water is 1:15, 50 mL of the polysaccharide solution is placed in a dialysis bag, and dialyzed with 6000 mL of deionized water for 68 hours, with the water changed every 3 hours for the first 12 hours and every 7 hours for the next 56 hours. After the dialysis of the polysaccharide solution is completed, the dialysate is concentrated, 4 times the volume of 90% ethanol is added thereto and mixed evenly, the mixed solution is placed at 2°C for overnight, centrifuged to obtain a precipitate, and the precipitate is vacuum freeze-dried to obtain rice bran polysaccharide.
[0077] Example 3
[0078] A method for extracting rice bran polysaccharides:
[0079] (1) Extraction of polysaccharides: 1.0 kg of rice bran screened with a 60-mesh sieve was mixed with 3 L of petroleum ether with a boiling range of 30-60°C, and placed in a fume hood and stirred for 2 h for defatting. After repeating this operation twice, the petroleum ether was filtered out, and the filter residue was air-dried in a fume hood. Defatted rice bran was extracted with distilled water at a mass ratio of 1:10 at 85°C for 3 h, extracted once, filtered, and the filtrate was centrifuged at a speed of 8000 r / min for 8 min, centrifuged once, the precipitate was removed, and the supernatant was retained.
[0080] (2) Removal of starch and protein: The supernatant obtained by the above centrifugation was further treated with a thermostable α-amylase (0.5 U / g) at 75°C for 1 h to degrade the starch, and the I2-KI solution test was negative. Then, 1000 U / mg of papain (0.5% by weight of rice bran) was added and reacted at 55°C for 3 h to degrade the protein. After boiling for 10 min to inactivate the enzyme activity, the supernatant was removed by centrifugation at 6000 r / min for 8 min to obtain the supernatant. The supernatant was mixed with Sevag reagent (chloroform: n-butanol volume ratio of 4:1) at a volume ratio of 1:1.5, stirred with a magnetic stirrer at 500 r / min for 20 min, poured into a separating funnel, and allowed to stand until the liquid was separated into three layers, the middle layer and the lower layer were removed, and the above operation was repeated 7 times until no significant protein layer appeared. The supernatant was collected and concentrated by a rotary evaporator, and then 2 times the volume of 98% ethanol solution was added to the concentrate. The suspension was placed in a refrigerator at 6° C. overnight and centrifuged to obtain a precipitate.
[0081] (3) Dialysis treatment
[0082] 1) Dialysis bag pretreatment: The molecular weight cutoff of the dialysis bag is 1500Da. The dialysis bag cut into appropriate length (about 20cm) is placed in a boiling water bath for 10 minutes. After cooling, it is immersed in a 15% ethanol solution by volume and stored in a refrigerator at 6°C for subsequent use.
[0083] 2) Polysaccharide dialysis: The precipitate obtained in step (2) is redissolved in distilled water to obtain a polysaccharide solution, the mass ratio of the precipitate to the distilled water is 1:6, 20 mL of the polysaccharide solution is placed in a dialysis bag, and dialyzed with 4000 mL of deionized water for 63 hours, with the water changed every 1.5 hours in the first 9 hours and every 9 hours in the next 54 hours. After the dialysis of the polysaccharide solution is completed, the dialysate is concentrated, 2 times the volume of 98% ethanol is added thereto and mixed evenly, the mixed solution is placed at 6°C for overnight, centrifuged to obtain a precipitate, and the precipitate is vacuum freeze-dried to obtain rice bran polysaccharide.
[0084] Test Example 1
[0085] Rice bran polysaccharides were extracted by the extraction method of Example 1, and detected with I2-KI solution after α-amylase treatment. The yield of rice bran polysaccharides was calculated using the following formula, and the total sugar content, sulfate content, protein content, total phenol content, and flavonoid content of the extracted rice bran polysaccharides were detected by phenol-sulfuric acid method, barium chloride-gelatin method, Coomassie brilliant blue method, Folin-Ciocalteu method, and aluminum salt colorimetry, respectively. The results are shown in Table 1.
[0086] The calculation formula of rice bran polysaccharide yield is as follows:
[0087]
[0088] Table 1 Physicochemical properties of rice bran polysaccharides
[0089] Detection indicators Rice bran polysaccharide Yield (%) 4.32 Total sugar content (%) 75.28±2.15 Sulfate content (%) - Protein content (%) 2.04±0.31 Total phenol content (mg / g) 1.25±0.25 Flavonoid content (mg / g) - <![CDATA[I2-KI solution]]> Negative
[0090] It can be seen from the results in Table 1 that the extraction rate of rice bran polysaccharides extracted by the extraction method of the present invention reaches 4.32%, the total sugar content in the polysaccharides reaches 75.28%, the impurity content is low, and the rice bran polysaccharides have high purity.
[0091] Test Example 2
[0092] The rice bran polysaccharide was extracted by the extraction method of Example 1, and the molecular weight of the rice bran polysaccharide was detected by high performance liquid chromatography. The monosaccharide composition of the rice bran polysaccharide was analyzed by high performance anion exchange chromatography amperometric detection. The repeating structural units of the rice bran polysaccharide were detected by methylation, one-dimensional and two-dimensional nuclear magnetic resonance. The results are as follows: Figure 1-Figure 4 shown.
[0093] Depend on Figure 1It can be seen that the molecular weight of rice bran polysaccharide is 3.72 kDa. Figure 2 It can be seen that the monosaccharide composition of rice bran polysaccharide is arabinose, galacturonic acid, glucose, galactose, xylose and glucuronic acid, and the molar ratio of each monosaccharide is arabinose: galacturonic acid: glucose: galactose: xylose: glucuronic acid = 6.95: 2.13: 82.93: 5.15: 2.07: 0.18.
[0094] Depend on Figure 3 and Figure 4 The results show that the repeating structural unit of rice bran polysaccharide is confirmed by methylation, one-dimensional and two-dimensional NMR:
[0095]
[0096] Test Example 3
[0097] 1. Experimental reagents
[0098] (1) Experimental animals: 6-week-old female SPF Balb / c mice were purchased and raised at the Animal Experiment Center of Zhejiang Academy of Medical Sciences, weighing about 17 g.
[0099] (2) Primers: All primers were synthesized by Shanghai Sangon Biotechnology Co., Ltd.
[0100] (3) Main experimental reagents: IL-4, INF-γMouse, Goat Anti-Mouse IgG1-HRP, Goat Anti-Mouse IgG2a-HRP, and Goat Anti-Mouse IgE-HRP antibodies were all purchased from Thermo Fisher; His ELISA was provided by Nanjing Jiancheng Biotechnology Co., Ltd.; FITC anti-mouse CD4 Antibody, APC anti-mouse IL-33Rα (ST2) Antibody, PE anti-mouse CD183 (CXCR3) Antibody, and Fc Block were all purchased from BD Biosciences, Inc.; RNA extraction kit was purchased from Omega Bio-Tek, Inc.; reverse transcription kit and fluorescent quantitative PCR kit were purchased from Shanghai Yishen Biotechnology Co., Ltd.; ovalbumin (OVA) and calcipotriol were purchased from Sigma Biologicals, Inc., USA. Other common chemical reagents were purchased from Shanghai Aladdin Co., Ltd. and were all analytically pure; rice bran polysaccharide (RBP) was obtained by the extraction method in Example 1.
[0101] 2. Construction of a model of rice bran polysaccharide alleviating OVA-mediated sensitization in Balb / c mice
[0102] Flow chart of the construction of the Balb / c mouse sensitization model and the experimental process Figure 5 shown.
[0103] (1) Mice were housed under specific pathogen-free conditions, with a room temperature of 25-28°C and a humidity of 40-60%, and provided with feed and water for daily diet. All animal procedures were approved by the Experimental Animal Welfare Ethics Committee of Zhejiang Provincial Experimental Animal Center. Balb / c mice were randomly divided into five groups, with 6 mice in each group, namely the control group (PBS group), the sensitized group (OVA group), and the rice bran polysaccharide RBP treatment group (RBPL group, RBPM group, and RBPH group).
[0104] (2) The mice were pre-fed for one week. The second and third weeks were the sensitization stage, specifically: 20 μL of MC903-ethanol solution (calcipotriol, 2 nmol as an adjuvant dissolved in 20 μL of anhydrous ethanol) was applied to both ears of the control group mice every day; 20 μL of an aqueous solution containing 100 μg of OVA and 20 μL of MC903-ethanol solution were applied to both ears of the sensitized group and each rice bran polysaccharide treatment group mice every day; the control group and the sensitized group were gavaged with 400 μL of PBS solution every day, and each rice bran polysaccharide treatment group was gavaged with 400 μL of rice bran polysaccharide RBP solution every day, and the rice bran polysaccharide concentrations were set as low-dose group (RBPL) = 5 mg / mL, medium-dose group (RBPM) = 10 mg / mL, and high-dose group (RBPH) = 15 mg / mL.
[0105] (3) The fourth week was the stimulation phase. On the 22nd day, the mice in the control group were gavaged with 400 μL PBS solution, and the mice in the sensitized group and the rice bran polysaccharide treatment group were gavaged with 400 μL OVA solution (125 mg / mL, PBS as solvent).
[0106] (4) Within 2 hours after stimulation, about 8 drops of blood were collected from the mouse using the orbital venous blood sampling method, and the blood was kept at 37°C for 1 hour. The blood was centrifuged at 3000 rpm for 10 minutes, and the supernatant was collected in an enzyme-free test tube and stored at -80°C. Subsequently, the mouse was subjected to the eyeball blood sampling method to extract as much blood as possible. After the mouse was killed, it was dissected under sterile conditions, and the spleen, large intestine, small intestine and other tissues were cut out in turn. A part of the spleen was quickly taken to measure T cell differentiation using flow cytometry, and the other tissues were placed in cryopreservation tubes, quickly frozen in liquid nitrogen, and transferred to a -80°C refrigerator for storage.
[0107] 3. Weekly weight changes of mice
[0108] During the entire period of mouse breeding, the mice were weighed on the first day of each week and their weight changes were observed. Figure 6 shown.
[0109] Depend on Figure 6The results show that in the first week of feeding, the weight of all mice in the groups increased because no allergens were added. In the second week of sensitization, the weight of all mice decreased, and the decrease was more obvious in the third week. Comparative analysis showed that after three weeks of feeding, the weight of mice in the OVA group decreased more significantly than that in the PBS group. This may be because under the stimulation of the allergen OVA, the absorption function of the intestinal mucosa of mice was destroyed, and the growth of mice was affected, resulting in weight loss. The weight of mice treated with different concentrations of rice bran polysaccharides was between the sensitized group and the control group, indicating that rice bran polysaccharides can alleviate the weight loss of mice caused by OVA sensitization, among which rice bran polysaccharide RBPM had the best effect.
[0110] 4. Clinical allergy symptom scoring of mice
[0111] The allergic symptoms of the mice were carefully observed 30 minutes after the stimulation, and the corresponding scores and evaluations were performed according to the set scoring criteria (Table 2). The sum of the scores constituted the clinical allergic symptom score of the mice. Figure 7 shown.
[0112] Table 2 Scoring criteria for clinical allergic symptoms in mice
[0113]
[0114]
[0115] When mice have an allergic reaction, they usually show clinical reactions such as scratching, piloerection, difficulty breathing and diarrhea. Therefore, scoring the clinical allergic symptoms of mice is an important indicator for evaluating the degree of allergy. Figure 7 As shown in the figure, the allergic symptoms of mice were observed and evaluated 30 minutes after stimulation. It was found that the allergic symptoms of mice in the OVA group were more severe than those in the PBS group, mainly manifested in more scratching times, thinner feces, and severe tremors. These symptoms are consistent with the typical clinical manifestations of allergies, indicating that the FA mouse model of epidermal exposure immunization has been successfully established. The allergic clinical symptom scores of mice in the rice bran polysaccharide treatment group were lower than those in the OVA group, but there was no significant difference in the allergic symptom scores among the rice bran polysaccharide treatment groups, indicating that rice bran polysaccharides can effectively alleviate the allergic phenomenon of mice caused by OVA, among which RBPM and RBPH have the best effect.
[0116] 5. Changes in rectal temperature of mice
[0117] The rectal temperature of the mice was measured before and 30 minutes after the stimulation, and the rectal temperature difference was obtained by subtracting the temperature before the stimulation from the temperature after the stimulation. Figure 8 shown.
[0118] Allergens can stimulate humoral immunity to produce IgE antibodies. When allergens invade the body again, mast cells can release histamine, which increases the permeability of blood vessel walls, leading to symptoms such as decreased body temperature and blood pressure. Therefore, monitoring changes in rectal temperature can be used as another indicator of the severity of systemic allergic reactions. Figure 8 As shown in the figure, the rectal temperature of mice was measured 30 minutes before and after the stimulation. It was found that the rectal temperature of mice in the PBS group increased after the stimulation, while that in the OVA group and the rice bran polysaccharide treatment group decreased, and the rectal temperature of mice in the OVA group decreased more than that in the rice bran polysaccharide treatment group. There was a significant difference in the rectal temperature difference between the rice bran polysaccharide-RBPM group and the OVA group, indicating that the stimulation of the allergen OVA can reduce the rectal temperature of mice, and the mice are in a sensitized state, and rice bran polysaccharides have a certain alleviating effect on the reduction of rectal temperature of mice caused by OVA sensitization.
[0119] 6. Determination of specific IgE, IgG2a, and IgG1 in mouse serum
[0120] Enzyme-linked immunosorbent assay (ELISA) was used to detect OVA-specific antibodies IgE, IgG2a, and IgG1 antibodies in mouse serum obtained by sampling eyeball blood before mice were killed.
[0121] 1) Pre-coat 100 μL of OVA solution (100 μg / mL) in an EIA / RIA 96-well plate and incubate at 4°C overnight.
[0122] 2) Pour out the coating solution in the coated 96-well plate, add 300 μL of washing solution (PBS + 0.05% Tween 20) to each well, shake at room temperature for 2 minutes, discard the washing solution and tap out the residual liquid in the well to ensure that no bubbles are generated during the operation. Repeat the washing operation 5 times to ensure that the residual liquid is thoroughly cleaned.
[0123] 3) Add 200 μL of blocking solution (PBS + 5% bovine serum albumin) to each well, and incubate the plate at 37°C for 1 hour. Then wash the plate 5 times with washing solution.
[0124] 4) Add 100 μL of diluted mouse serum sample to each well (use blocking solution to dilute serum, the dilution ratio is 1:10 for IgE, 1:200 for IgG2a, and 1:1000 for IgG1), and incubate at 37°C for 2 hours. After incubation, wash the plate 5 times with washing solution.
[0125] 5) Add 100 μL of secondary antibody (GoatAnti-Mouse IgE-HRP, GoatAnti-Mouse IgG2a-HRP, GoatAnti-Mouse IgG1-HRP, diluted 1:3000 before use) and incubate at 37°C for 1 hour. Then wash the plate again with washing solution for 5 times.
[0126] 6) Add 100 μL of 3,3',5,5'-tetramethylbenzidine (TMB) colorimetric solution to each well, then incubate the plate at 37°C in the dark for 15 min, then add 50 μL of stop solution (2M H2SO4 solution) to stop color development, and finally, use an ELISA reader to measure the OD value of each well at a wavelength of 450 nm. Fig. 9 shown.
[0127] The level of specific IgE antibodies in serum is currently recognized as the most effective evaluation index for detecting type I allergic reactions. In mice, Th2 reactions mainly produce IgE and IgG1 antibodies, while Th1 reactions produce IgG2a antibodies. Fig. 9 It can be seen that the IgE in the mouse serum was significantly increased due to OVA sensitization (OD increased from 0.312 to 0.613) (P < 0.0001); while the rice bran polysaccharide treatment group, especially the RBPM group, could significantly reduce the IgE level (OD decreased from 0.613 to 0.387), and even reached an effect that was not significantly different from the PBS group (0.312). After OVA sensitization, although IgG1 and IgG2a were upregulated, rice bran polysaccharide did not change IgG1, only RBPM upregulated IgG2a. The IgG2a / IgG1 ratio can reflect the Th1 / Th2 balance of the body, and Th1 cytokines can inhibit the differentiation of Th2 cells and the production of Th2 cytokines. Compared with the PBS group, the IgG2a / IgG1 ratio of the OVA group decreased, and the IgG2a / IgG1 ratio increased after the rice bran polysaccharide RBPM treatment, indicating that rice bran polysaccharide alleviated the allergic reaction in mice. Among them, the ability of different concentrations of polysaccharides to alleviate allergies was different, and RBPM had the best effect.
[0128] 7. Determination of histamine and cytokines in mouse serum
[0129] The concentrations of histamine, IL-4 and IFN-γ in mouse serum were determined according to the instructions of the mouse histamine kit and the mouse IL-4 and IFN-γ cytokine kit. Since histamine is unstable and easily degraded, mouse serum collected within 2 hours after stimulation was used. IL-4 and IFN-γ cytokines were measured using serum obtained by bleeding from the eyeballs of mice before they were killed.
[0130] 1) Place the kit at room temperature and equilibrate until the temperature is stable. Dilute and premix the required reagents according to the requirements of the kit. Add the diluted sample serum and serial dilution standard (50 μL) to the special ELISA plate in the kit in sequence and incubate at 37°C for 1 hour.
[0131] 2) Add 100 μL of HRP-labeled detection antibody to each well, seal the wells with sealing film, incubate the plate at 37°C for 1 hour, and then wash the plate three times with washing solution.
[0132] 3) Add 50 μL of substrate A and B solution to each well, seal the wells with sealing film, and incubate the wells at 37°C in the dark for 15 minutes. Then, add 50 μL of stop solution to terminate the reaction. Finally, use an ELISA reader to measure the OD value of each well at a wavelength of 450 nm. The results are as follows: Fig.10 shown.
[0133] When allergens stimulate the body to enter the effector phase, they induce various immune cells to secrete a series of cytokines, which eventually cause mast cells and basophils to release a large amount of histamine, which leads to vasodilation and increased permeability, and can promote bronchial mucus secretion, leading to the occurrence of food allergy symptoms. Therefore, histamine is an important indicator for directly assessing the severity of food allergies. Fig.10 As can be seen in Figure A, the histamine in the mouse serum was significantly increased due to OVA sensitization (from 19.15 ng / mL to 59.60 ng / mL), while the rice bran polysaccharide treatment group, especially RBPM, could significantly reduce the histamine level (19.27 ng / mL), and even achieved an effect that was not significantly different from the PBS group (19.15 ng / mL) (P < 0.0001).
[0134] To explore the effect of rice bran polysaccharides on T cells, the levels of Th1 cytokine IFN-γ and Th2 cytokine IL-4 were detected. Fig.10 As can be seen from B and C, OVA stimulation increased the levels of IFN-γ and IL-4. After adding RBPL, RBPM and RBPH, the downregulation ratio of IL-4 was 20.63%, 30.63% and 20.11%, respectively. However, the content of IFN-γ had no significant difference with the OVA group except for the RBPH group. The results showed that rice bran polysaccharides reduced Th2-related immune responses.
[0135] 8. Determination of mRNA expression of allergy-related cytokines in the spleen, large intestine and small intestine of mice
[0136] The spleen, large intestine and small intestine tissues frozen in -80℃ were taken out and ground into fine powder under liquid nitrogen conditions. RNA was extracted and synthesized into cDNA by reverse transcription using the corresponding kits. The mRNA expression of related genes (TSLP, IL-33, IL-6, IL-10, IL-4, GATA-3, IFN-γ, T-bet) was determined by RT-qPCR. GAPDH was used as the internal reference gene, and the relative expression of the target gene was calculated by 2 -ΔΔCt The result is as follows Figure 11-Figure 14 shown.
[0137] (1) Changes in the expression of allergy-related genes in intestinal epithelial cells in the large and small intestines of mice
[0138] Studies have shown that damage to the intestinal epithelial barrier will increase the amount of antigen permeation and promote the secretion of epithelial cytokines such as interleukin (IL)-33, IL-25 and thymic stromal lymphopoietin (TSLP). Fig.11 and Fig.12 It can be seen that in the large intestine and small intestine, under OVA stimulation, the expression levels of TSLP and IL-33 genes increased significantly, indicating that the intestines of mice were damaged after OVA stimulation and the body was in an allergic state. After treatment with various doses of rice bran polysaccharides, TSLP and IL-33, which were increased by OVA stimulation, decreased significantly (P < 0.05), and the degree of TSLP decrease was RBPM>RBPL>RBPH, and the degree of IL-33 decrease was RBPM>RBPH>RBPL, which showed that RBPM had a more obvious effect on epithelial cell factors TSLP and IL-33, and that the reduction in allergic reactions may be related to the reduction in IL-33 and TSLP gene expression in small intestinal cells.
[0139] (2) Changes in related gene expression in the spleen, large intestine, and small intestine of mice
[0140] As the largest immune organ in the body's blood circulation, the spleen can produce various immune active molecules including immunoglobulins and effector cells after being stimulated by antigens, and participate in immune responses. When foreign antigens appear in the blood, antigen presenting cells such as macrophages and dendritic cells in the spleen will phagocytize the foreign antigens, and at the same time, process and present antigen fragments to T cells, thereby initiating a specific immune response.
[0141] IL-6 is a DC-associated proinflammatory cytokine. Fig.13 As can be seen in Figure A, the gene expression of the allergic cytokine IL-6 in the spleen, large intestine, and small intestine was significantly upregulated under OVA stimulation (P < 0.01). The inhibitory effect of rice bran polysaccharide treatment on IL-6 gene expression was as follows: RBPL <RBPH<RBPM。
[0142] IL-10 is a Treg-related cytokine that can inhibit a variety of immune responses, including Th2 immune responses. Fig.13 As can be seen in Figure B, compared with the mice in the PBS group, the gene expression of the anti-inflammatory factor IL-10 in the spleen, large intestine and small intestine of the food-allergic mice was reduced, and the gene expression of IL-10 in the spleen and large intestine of the mice treated with rice bran polysaccharides was significantly increased (P < 0.01), while the gene expression of IL-10 in the small intestine was not significantly different from that in the OVA group.
[0143] (3) Changes in the expression of T cell allergy-related genes in the spleen, large intestine, and small intestine of mice
[0144] When a food allergy occurs, T cells will differentiate into Th2 cells and release Th2 cytokines to trigger subsequent allergic symptoms. The body will produce Th1 cytokines to inhibit the differentiation of Th2 cells and the secretion of their cytokines, thereby alleviating the allergic reaction.
[0145] Depend on Fig.14 It can be seen that after stimulation with the allergen OVA, the gene expression levels of Th2 cytokine IL-4 and transcription factor GATA-3 in the spleen and intestine of mice increased significantly (P < 0.01), indicating that OVA can promote Th2 inflammation in mice; after treatment with rice bran polysaccharides, the gene expression levels of Th2 cytokines decreased, indicating that at the genetic level, rice bran polysaccharides can regulate and inhibit the Th2 response in mice, and the degree of inhibition of rice bran polysaccharides is strongest in RBPM.
[0146] Depend on Fig.14 It can be seen that in the spleen and intestine, after sensitization with the allergen OVA, the gene expression levels of the Th1 cytokine IFN-γ and transcription factor T-bet in mice increased significantly (P < 0.05), indicating that OVA stimulated the production of Th1 immune response in mice; compared with the OVA group, there was no significant difference in the effect of rice bran polysaccharides on the expression of IFN-γ and T-bet genes, indicating that rice bran polysaccharides had no significant effect on Th1.
[0147] 9. Analysis of T cell differentiation in mouse spleen by flow cytometry
[0148] (1) Extraction of mouse spleen cells:
[0149] 1) After the mice were killed, they were soaked in 75% alcohol for 10 minutes and transferred to a biosafety cabinet under sterile operation. The mice were then dissected and the spleen was removed.
[0150] 2) After washing the spleen three times with sterile PBS solution, transfer the spleen to a sterile 200-mesh sieve placed in a culture dish, add 5 mL of PBS solution and slowly grind it. Collect the suspended liquid after grinding and filtration in a centrifuge tube, centrifuge at 4°C, 500g, for 5 minutes, and carefully discard the supernatant.
[0151] 3) Add 5 mL of red blood cell lysis buffer and gently pipette to resuspend the cell pellet. After standing at room temperature for 5 minutes, centrifuge at 4°C, 500g for 5 minutes and carefully discard the supernatant.
[0152] 4) Add 5 mL of PBS solution and gently pipette to resuspend the cell pellet. Centrifuge at 4°C, 500 g for 5 min, carefully discard the supernatant, and repeat washing twice with PBS solution.
[0153] (2) Flow cytometry analysis
[0154] 1) Collect cells: Collect the treated cells in a centrifuge tube, count the cells and divide into 100 μL / tube (the number is about 1×10 6 cells / tube). Add 50 μL BD Fc Block (recombinant protein derived from immunoglobulin, diluted 1:50) to 100 μL cells and incubate at 4°C for 15 min to block Fc receptors;
[0155] 2) Washing: Add 1 mL of 4°C precooled PBS solution to the centrifuge tube, centrifuge at 4°C, 500 g for 5 min, discard the supernatant, and repeat washing twice;
[0156] 3) Surface staining: resuspend the cell pellet after centrifugation with 100 μL of PBS, add 1 μL of surface antibody (CD4, CD183, ST2), mix gently, and incubate at 4°C in the dark for 30 min.
[0157] 4) Washing: Add 1 mL of 4°C precooled PBS solution to the centrifuge tube, centrifuge at 4°C, 500 g for 5 min, repeat washing twice, and finally resuspend the cells in 300 μL PBS.
[0158] 5) On-machine testing: Set the instrument parameters, first test the blank tube and the single-color tube, then test the experimental tube, and finally use the flow cytometer to analyze the data. Fig.15 shown.
[0159] In order to verify whether the T cells in the spleen of mice would undergo specific differentiation after being stimulated by OVA, flow cytometry was used to detect the spleen of mice to determine the ratio of Th1 and Th2 cells. Fig.15 As can be seen in A and B, the proportion of Th2 cells in CD4+ cells in the OVA group (1.75%) was significantly increased compared with the PBS group (1.29%) (P < 0.001), indicating that OVA stimulated the differentiation of Th0 cells into Th2 cells, enhanced the Th2 response, promoted the secretion of Th2 cytokines, and allergic symptoms appeared in mice. After treatment with rice bran polysaccharides RBPL, RBPM, and RBPH, the proportion of Th2 cells dropped significantly from 1.75% to 1.48%, 1.24%, and 1.30% (P < 0.05), indicating that rice bran polysaccharides can effectively weaken the differentiation of Th0 cells into Th2 cells stimulated by the allergen OVA, thereby inhibiting the Th2 response, among which RBPM had the most significant effect. The results of T cell differentiation were consistent with the results of RT-qPCR analysis of allergy-related genes.
[0160] Depend on Fig.15As shown in C and D, the proportion of Th1 cells in CD4+ cells in the OVA group (5.13%) was significantly higher than that in the PBS group (3.95%) (P < 0.001), indicating that mice stimulated by OVA were in a sensitized state, and OVA induced some Th0 cells to differentiate into Th1 cells, enhancing the Th1 response. However, the proportion of Th1 cells in the rice bran polysaccharide RBPL-treated group and the RBPM-treated group did not change significantly compared with the OVA group, and the proportion of Th1 cells differentiated by OVA stimulation decreased after the rice bran polysaccharide RBPH treatment.
[0161] 10. HE staining of mouse small intestine sections
[0162] Mouse ileum and duodenum tissues were fixed with 4% paraformaldehyde overnight and embedded in paraffin. The paraffin blocks were cut into 5 μm slices and further stained with hematoxylin-eosin (H&E). The integrity, cell morphology, and inflammatory cell infiltration of the ileum and duodenum were evaluated using a microscope. Fig.16 shown.
[0163] Intestinal tissue sections can be used to understand the condition of cells, the degree of inflammatory cell infiltration, and the damage to the intestine. Diarrhea caused by FA is usually related to intestinal inflammation. Fig.16 It can be seen that the intestinal wall of the mice in the PBS group was smooth and intact, the intestinal mucosa was slightly eroded, the intestinal villi were damaged at the end, and some villi were broken or missing, which may be due to the influence of adjuvant MC903. Compared with the PBS group, the intestinal wall of the mice in the OVA group showed shedding and infiltration, severe intestinal mucosal erosion, severe damage to the intestinal villi at the end, partial necrosis and shedding, thinning and breaking of the muscular layer; after treatment with different doses of rice bran polysaccharides, the damage of the intestinal villi of the mice was improved to varying degrees, among which the mucosa of the RBPM group and the RBPH group was intact, the intestinal villi were evenly arranged, and the degree of damage was relatively mild. Therefore, rice bran polysaccharide treatment can significantly improve OVA-induced ileal and duodenal tissue damage.
[0164] 11. mRNA expression of colon tissue-related factors
[0165] The corresponding kits were used to extract RNA from mouse colon tissues, synthesize cDNA, and then perform RT-qPCR to measure the expression of ZO-1, Occludin, and Claudin-1 genes. Fig.17 shown.
[0166] Tight junction proteins are an integral part of the intestinal physical barrier and play a key role in regulating the invasion of allergens and pathogenic bacteria. Fig.17It can be seen that compared with the PBS group, the expression levels of three key intestinal tight junction proteins ZO-1, Occludin and Claudin-1 decreased significantly after sensitization (P<0.0001), while the RBPM group and RBPH group significantly increased their expression levels, among which the protein levels of the three tight junction proteins ZO-1, Occludin and Claudin-1 in the RBPM treatment group were 46.81%, 34.11% and 51.68% higher than those in the model group, respectively. This indicates that intestinal barrier damage caused by food allergy can be alleviated by taking rice bran polysaccharides.
[0167] 12. Detection of NF-κB pathway proteins by western blotting
[0168] (1) Nuclear protein extraction
[0169] The nuclear protein and cytoplasm protein extraction kit method was used, and the specific steps were as follows: the spleen tissue was cut, and the cytoplasm protein extraction reagents A and B were mixed in a ratio of 20:1, and PMSF was added to make the final concentration 1mM, and the tissue homogenate was prepared and placed on ice for incubation for 30min. Then, it was centrifuged at 4℃, 1500g for 5min, and the supernatant obtained was part of the cytoplasm protein. The obtained precipitate was added with 100μL of cytoplasm protein extraction reagent A with PMSF added, mixed and incubated on ice for 30min, then 5μL of cytoplasm protein extraction reagent B was added, vortexed at high speed and incubated on ice for 1min. After that, it was centrifuged at 4℃ 12000rpm for 5min, and the supernatant obtained was another part of the cytoplasm protein. The obtained precipitate was added with 50 μL of nuclear protein extraction reagent supplemented with PMSF, and placed in an ice bath after high-speed vortexing. The mixture was vortexed at high speed for 30 seconds every 1 minute, and this step was continued for 30 minutes. Finally, it was centrifuged at 4°C and 12,000 rpm for 10 minutes. The supernatant obtained was the nuclear protein.
[0170] (2) Fully automatic wes detection
[0171] Antibody used: NF-κB p65 (D14E12) Rabbit mAb: CST 8242
[0172] Phospho-NF-κB p65(Ser536)(7F1)Mouse mAb: CST 3036
[0173] LaminA / C Antibody: CST 2032
[0174] The analysis was performed using a fully automatic western detection kit and a fully automatic western analyzer. The specific method is as follows:
[0175] Prepare DTT: Add DTT powder to 40 μL of deionized water and mix well;
[0176] Prepare 5×MasterMix (i.e., Loading Buffer): Add 20 μL DTT solution and 20 μL 10×Sample Buffer to the MasterMix powder and pipette evenly;
[0177] Prepare Ladder (i.e. marker): Add Ladder powder into 20 μL of deionized water and dissolve for later use;
[0178] Prepare samples: add 3 μL of sample to the well plate, place the prepared ladder and sample in a 95°C environment for denaturation for 5 minutes; cool on ice for 5 minutes after denaturation; vortex and mix after cooling, centrifuge, and place on ice for later use;
[0179] Prepare primary antibody: dilute Antibody Diluent II 1:50 and place on ice for later use. Add 10 μL of diluted primary antibody to each well.
[0180] Prepare luminescent solution: Take 200 μL each of Lumino-S and Peroxide, vortex to mix, and place on ice for later use;
[0181] Take out the sample plate from the orange test kit and add the prepared reagents into the plate in sequence:
[0182] Row A: A1 is ladder, 5 μL, and the remaining wells are samples, 3 μL;
[0183] Row B: Antibody Diluent II (antibody diluent), volume 10 μL;
[0184] Row C: C1 is Antibody Diluent II, and the remaining wells are diluted primary antibodies, with a volume of 10 μL;
[0185] Row D: D1 is Streptavidin-HRP, and the remaining wells are the corresponding secondary antibodies, with a volume of 10 μL;
[0186] Row E: luminescent solution, volume 15 μL;
[0187] Line F: Empty
[0188] Add 500 μL Wash Buffer to each well in row F.
[0189] The lid was closed, and the mixture was centrifuged at 2500 rpm for 5 min at room temperature after balancing. After all samples were added, they were tested on an automatic western analyzer, and the results were analyzed and processed using ProteinSimple 6.0.0 software. Fig.18 shown.
[0190] As an important nuclear transcription factor, NF-κB plays a key role in regulating the activation of immune cells, the maturation of T and B lymphocytes, apoptosis, inflammatory response and various autoimmune diseases. Fig.18 It can be seen that NF-κB was activated in the OVA group, and the protein expression level of p-NF-κB in the nucleus and the ratio of p-NF-κB to NF-κB were increased compared with the PBS group. After receiving rice bran polysaccharide treatment, the protein expression level of p-NF-κB in the nucleus and the ratio of p-NF-κB to NF-κB in allergic mice were downregulated. The results show that rice bran polysaccharides may exert anti-allergic effects by regulating the NF-κB signaling pathway in the spleen of allergic mice.
[0191] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A rice bran polysaccharide, characterized in that: The molecular weight of the rice bran polysaccharide is 3.72 kDa, and the monosaccharide composition of the rice bran polysaccharide includes arabinose, galacturonic acid, glucose, galactose, xylose and glucuronic acid, and the molar ratio of arabinose, galacturonic acid, glucose, galactose, xylose and glucuronic acid is 6.95:2.13:82.93:5.15:2.07:0.
18.
2. The rice bran polysaccharide according to claim 1, characterized in that The rice bran polysaccharide structure comprises: →[4)-α-D-Glcp-(1) n →6)-β-D-Galp-(1→4)-α-D-Glcp-(1→4)-α-D-Glcp-(1→circular is the main chain, and the side chains include α-D-Glcp-(1→ connected to the O-6 position of the sugar residue →4,6)-α-D-Glcp-(1→ and α-L-Araf-(1→ connected to the O-3 position of the sugar residue →3,6)-β-D-Galp-(1→).
3. The method for extracting rice bran polysaccharides according to claim 1 or 2, characterized in that: The extraction method comprises the following steps: The rice bran is mixed with petroleum ether for defatting to obtain defatted rice bran; the defatted rice bran is extracted in water and the supernatant is collected; α-amylase, papain and Sevag method are used to remove starch and protein in the supernatant and the supernatant from which the starch and protein are removed is collected; the supernatant from which the starch and protein are removed is concentrated and precipitated with alcohol to obtain a precipitate; the precipitate is dialyzed with deionized water to obtain a dialysate; the dialysate is concentrated and precipitated with alcohol and the precipitate is dried to obtain rice bran polysaccharide.
4. The extraction method according to claim 3, characterized in that The extraction conditions are: leaching at 85-95° C. for 1-3 hours.
5. The extraction method according to claim 3, characterized in that The α-amylase treatment conditions are: treatment at 75-85° C. for 0.2-1 h.
6. The extraction method according to claim 3, characterized in that The papain treatment conditions are: treatment at 55-65° C. for 1-3 hours.
7. The extraction method according to claim 3, characterized in that The molecular weight cut-off of the dialysis is 1500-2500Da.
8. Use of the rice bran polysaccharide according to claim 1 or 2 in the preparation of a product for preventing and / or treating food allergies.
9. A drug for preventing and / or treating food allergies, characterized in that: The medicine comprises a pharmaceutically acceptable carrier and the rice bran polysaccharide according to claim 1 or 2.
10. The drug according to claim 9, characterized in that The dosage form of the drug includes oral preparation, spray or injection.
